← Mechanisms of action
SLC12A3
SINGLE PROTEINHomo sapiens
Preferred name: Thiazide-sensitive sodium-chloride cotransporter ChEMBL ↗
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| quinethazone (hydromox) | Antagonist | approved | Small molecule | SLC12A3 antagonist |
| bendroflumethiazide (naturetin) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| benzthiazide (fovane) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| chlorothiazide (diuril) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| chlorthalidone (Hygroton) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| cyclothiazide (anhydron) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| hydrochlorothiazide (esidrix) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| hydroflumethiazide (saluron) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| indapamide (lozol) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| methyclothiazide (enduron) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| metolazone (zaroxolyn) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| natrunix | Inhibitor | experimental | mAb | SLC12A3 inhibitor |
| polythiazide (renese) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |
| trichlormethiazide (naqua) | Inhibitor | approved | Small molecule | SLC12A3 inhibitor |